Hops for Menopausal Vasomotor Symptoms: Mechanisms of Action
1
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
Menopause is a critical stage of women’s life associated with various complaints and distresses. Vasomotor symptoms (VMS), such as hot flushes, night sweats, sleep disturbances, and fatigue, are the most common menopause symptoms affecting about 50% to 80% of middle-aged women. Obviously, these symptoms, resulting from estrogen deficiency during menopause, can exert negative effects on women’s health and quality of life and thus require to be managed through approaches such as hormone replacement therapy (HRT). Many herbal treatments for menopause symptoms contain and its components such as 8-prenylnaringenin, 6-PN, isoxanthohumol and xanthohumol. Recent in-vivo studies have highlighted the ability of 8-prenylnaringenin to reduce serum-luteinizing hormone (LH) and follicle-stimulating hormone (FSH), to increase serum prolactin levels and uterine weight, and to induce vaginal hyperplastic epithelium. Previous research has shown that hops extract can strongly bind to both estrogen receptors, stimulate alkaline phosphatase activity in Ishikawa cells, and upregulate presenelin-2 and progesterone receptor mRNA in Ishikawa cells. Numerous clinical trials have documented significant reductions in the frequency of hot flushes following the administration of hop-containing preparations. Nevertheless, further clinical trials with larger sample size and longer follow-up are warranted to confirm such benefits. (J Menopausal Med 2016;22:62-64)
Abstract
Menopause is a critical stage of women’s life associated with various complaints and distresses. Vasomotor symptoms (VMS), such as hot flushes, night sweats, sleep disturbances, and fatigue, are the most common menopause symptoms affecting about 50% to 80% of middle-aged women. Obviously, these symptoms, resulting from estrogen deficiency during menopause, can exert negative effects on women’s health and quality of life and thus require to be managed through approaches such as hormone replacement therapy (HRT). Many herbal treatments for menopause symptoms contain and its components such as 8-prenylnaringenin, 6-PN, isoxanthohumol and xanthohumol. Recent in-vivo studies have highlighted the ability of 8-prenylnaringenin to reduce serum-luteinizing hormone (LH) and follicle-stimulating hormone (FSH), to increase serum prolactin levels and uterine weight, and to induce vaginal hyperplastic epithelium. Previous research has shown that hops extract can strongly bind to both estrogen receptors, stimulate alkaline phosphatase activity in Ishikawa cells, and upregulate presenelin-2 and progesterone receptor mRNA in Ishikawa cells. Numerous clinical trials have documented significant reductions in the frequency of hot flushes following the administration of hop-containing preparations. Nevertheless, further clinical trials with larger sample size and longer follow-up are warranted to confirm such benefits. (J Menopausal Med 2016;22:62-64)
참고문헌 (18)
- Abdi F, "Protocol for systematic review and meta-analysis: hop (Humulus lupulus L.) for menopausal vasomotor symptoms", BMJ Open, 6, pp.e010734~ (2016)
- Dennerstein L, "New findings from non-linear longitudinal modelling of menopausal hormone changes", Hum Reprod Update, 13, pp.551~557 (2007)
- Abdi F, "Effects of hormone replacement therapy on immunological factors in the postmenopausal period", Climacteric, 19, pp.234~239 (2016)
- Fatemeh Shobeiri, "Quality of Life in Postmenopausal Women in Iran: A Population-based Study", 대한폐경학회지, 22(1), pp.31~38 (2016), 대한폐경학회
- Birrer N, "Is hormone replacement therapy safe in women with a BRCA mutation?: A systematic review of the contemporary literature", Am J Clin Oncol (2016)
- Abdi F, "Hormone therapy for relieving postmenopausal vasomotor symptoms: A systematic review", Arch Iran Med, 19, pp.141~146 (2016)
- van Breemen RB, "Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hops", Mol Nutr Food Res, 58, pp.1962~1969 (2014)
- Milligan SR, "The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids", J Clin Endocrinol Metab, 85, pp.4912~4915 (2000)
- Schaefer O, "8-Prenyl naringenin is a potent ERalpha selective phytoestrogen present in hops and beer", J Steroid Biochem Mol Biol, 84, pp.359~360 (2003)
- Seung Do Choi, "Is Complementary and Alternative Therapy Effective for Women in the Climacteric Period?", 대한폐경학회지, 21(1), pp.28~35 (2015), 대한폐경학회
- Mohammad-Alizadeh-Charandabi S, "Efficacy of hop (Humuluslupulus L.) on early menopausal symptoms in perimenopausal women: A randomized double blind placebo-controlled trial", Sci J Kurdistān Univ Med Sci, 19, pp.12~22 (2014)
- Bowe J, "The hop phytoestrogen, 8-prenyl-naringenin, reverses the ovariectomy-induced rise in skin temperature in an animal model of menopausal hot flushes", J Endocrinol, 191, pp.399~405 (2006)
- Zanoli P, "Pharmacognostic and pharmacological profile of Humulus lupulus L", J Ethnopharmacol, 116, pp.383~396 (2008)
- Erkkola R, "A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts", Phytomedicine, 17, pp.389~396 (2010)
- Heyerick A, "A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts", Maturitas, 54, pp.164~175 (2006)
- Christoffel J, "Effects of 8-pre-nylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment", J Endocrinol, 188, pp.397~405 (2006)
- Aghamiri V, "The effect of Hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes:A randomized placebo-controlled trial", Complement Ther Clin Pract, 23, pp.130~135 (2016)
- Rosic S, "Phytoestrogens impact on menopausal symptomatology", Mater Sociomed, 25, pp.98~100 (2013)